Siqing Yu

Siqing Yu

Auto-generated profile, based on publicly available information

Siqing Yu

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SYSiqing Yu
Siqing Yu
BFBeatrice E Frueh
Beatrice E Frueh
DSDagmar Steinmair
Dagmar Steinmair
AEAndreas Ebneter
Andreas Ebneter
SWSebastian Wolf
Sebastian Wolf
MMMarion R Munk
Marion R Munk
To analyze retinal blood flow before and after cataract surgery using swept-source optical coherence tomography angiography (SS-OCTA). Prospective observational study. Consecutive patients were recruited and scanned using SS-OCTA before and after cataract surgery. Laser flare photometry were performed post-surgery. Perfusion and vessel density of superficial (SCP) and deep capillary plexuses (DCP) of the 3 × 3 mm images as well as foveal avascular zone (FAZ) measurements were assessed. Vessel continuity, vessel visibility and presence of artefacts were evaluated by two blinded graders using a predefined grading protocol. Thirteen eyes of 12 patients met the inclusion criteria. There was a significant increase of perfusion and vessel densities in both the SCP and the DCP after cataract surgery within the 3 × 3 mm images. Significantly better distinguishability of FAZ border was observed postoperatively in both SCP and DCP, however, FAZ area and perimeter measurements did not significantly change after cataract surgery. Mean number of motion artifacts in SCP and DCP numerically decreased by 37% (P = .089) and 42% (P = .080). Lens opacities have a significant influence on retinal blood flow measurements in SS-OCTA and should be considered in quantitative vessel analysis. Inflammation may also impact the assessment of density parameters. FAZ measurements seems to be the most robust parameters in terms of media opacity.

19 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TKThomas Kurmann
Thomas Kurmann
SYSiqing Yu
Siqing Yu
PMPablo Márquez-Neila
Pablo Márquez-Neila
AEAndreas Ebneter
Andreas Ebneter
MZMartin Sebastian Zinkernagel
Martin Sebastian Zinkernagel
RSRaphael Sznitman
Raphael Sznitman
In ophthalmology, retinal biological markers, or biomarkers, play a critical role in the management of chronic eye conditions and in the development of new therapeutics. While many imaging technologies used today can visualize these, Optical Coherence Tomography (OCT) is often the tool of choice due to its ability to image retinal structures in three dimensions at micrometer resolution. But with widespread use in clinical routine, and growing prevalence in chronic retinal conditions, the quantity of scans acquired worldwide is surpassing the capacity of retinal specialists to inspect these in meaningful ways. Instead, automated analysis of scans using machine learning algorithms provide a cost effective and reliable alternative to assist ophthalmologists in clinical routine and research. We present a machine learning method capable of consistently identifying a wide range of common retinal biomarkers from OCT scans. Our approach avoids the need for costly segmentation annotations and allows scans to be characterized by biomarker distributions. These can then be used to classify scans based on their underlying pathology in a device-independent way.

1 January 2019 in Retina
Verified
Journal Article
Open access
PAPetra Arendt
Petra Arendt
SYSiqing Yu
Siqing Yu
MMMarion R. Munk
Marion R. Munk
AEAndreas Ebneter
Andreas Ebneter
SWSebastian Wolf
Sebastian Wolf
MZMartin Sebastian Zinkernagel
Martin Sebastian Zinkernagel
Purpose: To evaluate the outcome of an exit strategy in a treat-and-extend regimen for neovascular age-related macular degeneration. Methods: Five hundred and ninety-eight eyes of 488 patients with neovascular age-related macular degeneration receiving intravitreal anti–vascular endothelial growth factor injections according to a treat-and-extend regimen were included in this retrospective study. A treat-and-extend regimen with either interval extension by 2 weeks or shortening by 1 week was used. “Exit criteria” were defined as 3 consecutive injections 16 weeks apart with stable findings after which the patient was exited from treatment and followed up at 3 to 4 monthly intervals without therapy. Best-corrected visual acuity, central retinal thickness at treatment initiation and termination, incidence of recurrence after treatment termination, presence of characteristics in the optical coherence tomography, duration of therapy, number and intervals of injections were analyzed. Results: Seventeen percent of all included eyes met the exit criteria. The mean number of anti–vascular endothelial growth factor injections was 23.7 ± 14.7 with a mean treatment duration of 4.5 ± 2.5 years. Twelve percent reached exit with the minimal number of injections. Thirteen percent had recurrent disease after a mean of 37 ± 16 weeks. In the subgroup with recurrent disease, rate of pigment epithelial detachment at treatment termination was significantly higher than without recurrence (77% vs. 30%, P = 0.0018) with a significant higher proportion of serous pigment epithelial detachment (31% vs. 7%, P = 0.0247). Conclusion: The high percentage of patients meeting the exit criteria and the relatively low incidence of recurrences underline the usefulness of a predefined exit strategy. However, in a subgroup of patients, continuation of therapy may be advisable.

1 April 2018 in Ophthalmology Retina
Verified
Journal Article
Closed access
MMMarion R Munk
Marion R Munk
PAPetra Arendt
Petra Arendt
SYSiqing Yu
Siqing Yu
LCLala Ceklic
Lala Ceklic
WHWolfgang Huf
Wolfgang Huf
MZMartin S. Zinkernagel
Martin S. Zinkernagel

24 March 2016 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
QLQianyi Lu
Qianyi Lu
CZChen Zou
Chen Zou
HCHui Cao
Hui Cao
MZMinjie Zhao
Minjie Zhao
SYSiqing Yu
Siqing Yu
ZZZhi Zheng
Zhi Zheng

22 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DPDaniel Pauleikhoff
Daniel Pauleikhoff
MGMarie-Luise Gunnemann
Marie-Luise Gunnemann
MZMartin Ziegler
Martin Ziegler
BHBritta Heimes-Bussmann
Britta Heimes-Bussmann
EBEike Bormann
Eike Bormann
LPLaurenz Pauleikhoff
Laurenz Pauleikhoff
Purpose: To analyze the morphological changes of macular neovascularization (MNV) in exudative neovascular age-related macular degeneration under long-term intravitreal anti-vascular endothelial growth factor (VEGF) therapy in a retrospective cohort study. Methods and patients: We evaluated 143 nAMD eyes of 94 patients (31 male, 63 female; initial age 55–97 y, mean age 75.9 ± 7.5 y), who started anti-VEGF therapy (IVAN pro re nata (PRN) protocol) between 2009–2018 and received ongoing therapy until the last recorded visit (mean follow-up 5.3 ± 2.9 y, range 1–14 y). The mean total number of injections was 33.3 ± 19.8 with 7.0 ± 2.3 injections/year. MNV size and, if present, associated complete retinal pigment epithelium (RPE) and outer retina atrophy (cRORA) size were measured on optical coherence tomography (OCT) volume scans at the initial visit and for each year of follow-up. MNV and cRORA were identified on B-scans and their respective borders were manually transposed onto the en-face near infrared image and measured in mm2. Results: MNV enlarged through follow-up, with a mean growth rate of 1.24 mm2 / year. The mean growth in MNV size was independent of initial MNV size, age, gender, MNV subtypes or number of injections per year. Nevertheless, a great interindividual variation in size and growth was observed. cRORA developed in association with increasing MNV size and its incidence increased linearly over follow-up. cRORA lesions also showed continuous growth by a rate of 1.22 mm2 / year. Conclusions: Despite frequent long-term anti-VEGF therapy, we observed ongoing MNV growth. This is consistent with the concept that the development of MNV may be a physiological biological repair mechanism to preserve RPE and photoreceptor function, provided hyperpermeability and fluid exudation are controlled. Whether recurring low VEGF levels or other factors are responsible for MNV growth remains controversial.